This is a preview of subscription content, log in via an institution to check access.
Literature Cited
P. G. Glushankov, S. L. Buldakova, V. G. Skrebitskii, et al., Byull. Éksp. Biol. Med., No. 10, 44 (1982).
T. Asano and N. Ogasawara, Eur. J. Pharmacol.,80, 271 (1982).
C. Braestrup, M. Nielsen, and C. Olsen Proc. Natl. Acad. Sci. USA,77, 2288 (1980).
S. Faugier-Grimaud, Neuropharmacology,17, 905 (1978).
H. Mohler and T. Okada, Science,198, 849 (1977).
H. Mohler, Eur. J. Pharmacol.,80, 435 (1982).
M. Nielsen, C. Braestrup, and R. F. Squires Brain Res.,141, 342 (1978).
D. J. Nutt and P. J. Cowen, Nature,295, 436 (1982).
H. Rommelspacher, C. Nanz, H. O. Barbe, et al., Eur. J. Pharmacol.,70, 409 (1981).
W. Sieghart and M. Karobath, Nature,286, 285 (1980).
P. Skolnick, P. J. Marangos, F. K. Goodwin, et al., Life Sci.,23, 1473 (1978).
R. F. Squires and C. Braestrup, Nature,266, 732 (1977).
Rights and permissions
About this article
Cite this article
Glushankov, P.G., Skrebitskii, V.G. Effect of the specific benzodiazepine antagonist R015-1788 on inhibition of hippocampal unit activity evoked by phenazepam. Bull Exp Biol Med 96, 1569–1572 (1983). https://doi.org/10.1007/BF00835292
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00835292